Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncology Therapeutics Network

Executive Summary

Recent technological upgrades help explain a lower-than-usual 17% growth rate during second quarter, Bristol's Winningham explains. An e-commerce initiative undertaken in 1999 has "been able to help physician's offices carry lower relative inventories of oncology products." Similarly, the installation of 750 dispensing machines in oncologist's offices in the U.S. has reduced inventory levels. The new services, coupled with a lack of new oncology product launches in the first half of 2000, explain the drop-off from 36% growth in 1999, he said
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS036426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel